Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History | Funding Information
International Journal of Nursing & Clinical Practices Volume 3 (2016), Article ID 3:IJNCP-212, 3 pages
https://doi.org/10.15344/2394-4978/2016/212
Original Article
Alternate Day Statin Dosing for Women with Previous Statin Intolerance

Margo Minissian1*, Talya Waldman1, Chrisandra Shufelt1, Megha Agarwal4, Puja K. Mehta2, Galen Cook-Wiens1, Jo Ann Eastwood3 and Noel Bairey Merz1

1Barbra Streisand Women’s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States
2Emory Women’s Heart Center, Atlanta, Georgia, United States
3University of Los Angeles, School of Nursing, Los Angeles, California, United States
4Ventura Cardiology Consultants, Ventura, California, United States
Margo Minissian, PhDc, ACNP, Barbra Streisand Women’s Heart Center, Cedars-Sinai Heart Institute, 127 San Vicente AHSP suite A9306, Los Angeles, CA 90048, United States; E-mail: minissianm@cshs.org
29 September 2016; 01 December 2016; 03 December 2016
Minissian M, Waldman T, Shufelt C, Agarwal M, Mehta PK, et al. (2016) Alternate Day Statin Dosing for Women with Previous Statin Intolerance. Int J Nurs Clin Pract 3: 212. doi: https://doi.org/10.15344/2394-4978/2016/212
This work was supported by contracts from the National Heart, Lung and Blood Institutes:1F31NR015725-01, N01-HV-68161, N01- HV-68162, N01-HV-68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, T32HL69751, 1R03AG032631 from the National Institute on Aging, GCRC grant MO1-RR00425 from the National Center for Research Resources and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women’s Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad Women’s Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California, and the Barbra Streisand Women’s Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles.
© 2016 Minissian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, et al. (2009) Deaths: final data for 2006. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 57: 1-134 [View]
  2. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. (2011) Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation 123: 1243-1262 [CrossRef] [Google Scholar] [PubMed]
  3. America's Cholesterol Burden January 30,2012 [View]
  4. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 13: 227-239 [CrossRef] [Google Scholar] [PubMed]
  5. Bellasi A, Raggi P, Merz CN, Shaw LJ (2007) New insights into ischemic heart disease in women. Cleve Clin J Med 74: 585-594 [Google Scholar] [PubMed]
  6. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM (2004) Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 19: 638-645 [CrossRef] [Google Scholar] [PubMed]
  7. Sewright KA, Clarkson PM, Thompson PD (2007) Statin myopathy: incidence, risk factors, and pathophysiology. Curr Atheroscler Rep 9: 389- 396 [Google Scholar] [PubMed]
  8. Pasternak RC, Smith SC Jr., Bairey-Merz CN, Grundy SM, Cleeman JI, et al. (2002) ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Journal of the American College of Cardiology 40: 567-72 [CrossRef] [Google Scholar] [PubMed]
  9. Lopez LM (2005) Rosuvastatin: a high-potency HMG-CoA reductase inhibitor. J Am Pharm Assoc (2003) 45: 503-513 [CrossRef] [Google Scholar] [PubMed]
  10. Gadarla M, Kearns AK, Thompson PD (2008) Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins. Am J Cardiol 101: 1747-1748 [CrossRef] [Google Scholar] [PubMed]
  11. Backes JM, Venero CV, Gibson CA, Ruisinger JF, Howard PA, et al. (2008) Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother 42: 341-346 [CrossRef] [Google Scholar] [PubMed]
  12. Ruisinger JF, Backes JM, Gibson CA, Moriarty PM (2009) Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance. Am J Cardiol 103: 393-394 [CrossRef] [Google Scholar] [PubMed]
  13. Matalka MS, Ravnan MC, Deedwania PC (2002) Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). Am Heart J 144: 674-677 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.